Table 7.
Variables | Satisfaction with Breasts | p | Satisfaction with the Reconstruction of the NAC | p | |
---|---|---|---|---|---|
Smoking | No | 54.37 (17.57) | 0.83 * | 2.64 (1.21) | 0.10 *** |
Yes | 55.47 (15.29) | 1.75 (1.16) | |||
Education level | Primary education | 55.89 (11.46) | 0.35 ** | 1.71 (1.50) | 0.44 **** |
Secondary education | 50.50 (22.28) | 2.63 (1.18) | |||
University degree | 60.44 (16.77) | 2.75 (1.21) | |||
Previous breast surgery | No | 56.50 (17.79) | 0.66 * | 2.40 (1.15) | 0.63 *** |
Yes | 54.08 (14.35) | 2.63 (1.40) | |||
Localization of primary tumor | Upper-outer | 56.61 (15.89) | 0.79 ** | 2.58 (1.21) | 0.35 **** |
Upper-inner | 58.33 (11.69) | 2.80 (1.30) | |||
Lower-outer | 53.00 (5.56) | 3.00 (0.00) | |||
Lower-inner | 51.80 (12.29) | 1.00 (0.00) | |||
Central | 47.40 (32.62) | 1.50 (0.57) | |||
Stage | 0 | 43.50 (7.78) | 0.65 ** | 1.00 (0.00) | 0.80 **** |
I | 58.67 (25.66) | 2.00 (1.15) | |||
IIA-B | 53.96 (15.92) | 2.19 (1.17) | |||
IIIA-B | 57.56 (8.08) | 2.00 (1.41) | |||
Type of mastectomy | Skin-sparing type I–II | 50.71 (15.50) | 0.35 ** | 1.91 (1.13) | 0.07 **** |
Skin-sparing type IV | 62.00 (14.85) | 2.80 (0.83) | |||
Nipple skin-sparing | 61.00 (20.03) | 3.22 (0.97) | |||
Radical mastectomy | 56.44 (16.85) | 2.13 (1.35) | |||
Breast reconstruction timing | Immediate | 56.60 (15.28) | 0.60 * | 2.55 (1.17) | 0.11 *** |
Delayed | 47.50 (31.77) | 1.00 (0.00) | |||
Type of reconstruction | Expander-prosthesis | 53.33 (15.25) | 0.82 ** | 2.44 (0.88) | 0.92 **** |
Becker expander | 58.67 (17.91) | 2.25 (1.16) | |||
Latissimus dorsi muscle flap | 58.30 (8.73) | 2.40 (1.51) | |||
Matrix acellular | 58.60 (13.66) | 2.80 (1.64) | |||
Direct prosthesis | 51.00 (28.67) | 2.50 (1.37) | |||
Lymph node management | None | 52.92 (17.20) | 0.20 ** | 2.45 (1.26) | 0.44 **** |
Sentinel lymph node biopsy | 57.59 (16.26) | 2.44 (1.26) | |||
Axillary lymph node dissection | 73.50 (6.36) | 2.33 (1.17) | |||
Adjuvant Radiotherapy | No | 55.32 (20.71) | 0.78 * | 2.47 (1.26) | 0.92 *** |
Yes | 56.57 (9.99) | 2.43 (1.15) | |||
Chemotherapy | No | 56.89 (19.73) | 0.94 ** | 2.18 (1.16) | 0.99 **** |
Neo-adjuvant | 55.08 (21.01) | 2.20 (1.30) | |||
Adjuvant | 55.37 (10.79) | 2.22 (1.20) | |||
Breast symmetrisation | No | 57.82 (22.55) | 0.55 * | 2.17 (1.19) | |
Yes | 54.81 (13.15) | 2.62 (1.20) | |||
Evolution | Successful | 55.29 (17.44) | 0.83 * | 2.69 (1.18) | 0.39 *** |
Reoperation | 56.29 (16.67) | 2.30 (1.21) |
* p-value obtained by t-Student; ** p-value obtained by ANOVA; *** p-value obtained by Mann Whitney U; **** p- value obtained by Kruskal-Wallis.